Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/235.8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)
Description: Subject matter in which the additional hetero ring contains plural ring nitrogens.

Sub-classes under this class:

Class Number	Class Name	Patents
514/236.5	The ring nitrogens are bonded directly to each other (e.g., pyridazine, etc.)	203
514/236.2	Three or more ring hetero atoms in the additional hetero ring	342

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Patent Number	Title Of Patent	Date Issued
6740636	Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection	May. 25, 2004
6740652	Oxazolidinones to treat eye infections	May. 25, 2004
6730683	Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses	May. 4, 2004
6723742	Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators	Apr. 20, 2004
6720322	Butyne diol derivatives	Apr. 13, 2004
6720319	Compounds useful as reversible inhibitors of cysteine proteases	Apr. 13, 2004
6720321	1,4-disubstituted benzo-fused cycloalkyl urea compounds	Apr. 13, 2004
6713472	Thiazine or pyrazine derivatives	Mar. 30, 2004
6710048	Pyrazine derivatives as modulators of tyrosine kinases	Mar. 23, 2004
6710044	Technical field	Mar. 23, 2004
6706710	Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]- 4-morpholinobenzamide	Mar. 16, 2004
6703397	Pyrimidinyl methyl indole derivatives with antibacterial activity	Mar. 9, 2004
6699856	Pyrazinones, compositions containing such compounds and methods of use	Mar. 2, 2004
6699864	Substituted phenyl-piperazine derivatives, their preparation and use	Mar. 2, 2004
6696426	Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems	Feb. 24, 2004
6689778	Inhibitors of Src and Lck protein kinases	Feb. 10, 2004
6689779	Oxazolidinone derivatives and a process for the preparation thereof	Feb. 10, 2004
6677337	1,2-dihydropyrazol-3-ones which controls inflammatory cytokines	Jan. 13, 2004
6677336	Substituted piperazine compounds	Jan. 13, 2004
6670363	Azole compounds as therapeutic agents for fungal infections	Dec. 30, 2003
6664255	Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade	Dec. 16, 2003
6660731	Pyrazole compounds useful as protein kinase inhibitors	Dec. 9, 2003
6653313	1,4-dihydropyridine compounds as bradykinin antagonists	Nov. 25, 2003
6649611	Piperazine derivatives	Nov. 18, 2003
6645963	Prolonged-action eye drop	Nov. 11, 2003
6642227	Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases	Nov. 4, 2003
6638930	Morpholine and thiomorpholine tachykinin receptor antagonists	Oct. 28, 2003
6635636	Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them	Oct. 21, 2003
6627627	Aralkyl and aralkylidene heterocyclic lactams and imides	Sep. 30, 2003
6620826	Endothelin receptor antagonists	Sep. 16, 2003
6617324	Substituted pyrazoles as p38 kinase inhibitors	Sep. 9, 2003
6613764	Aspartic protease inhibitors	Sep. 2, 2003
6610677	Pyrazole compounds useful as protein kinase inhibitors	Aug. 26, 2003
6596719	6 alkoxy-4-pyrimidinyl bis-sulfonamides	Jul. 22, 2003
6596720	Anti-HIV compositions	Jul. 22, 2003
6596750	Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators	Jul. 22, 2003
6593327	Compounds and compositions as protease inhibitors	Jul. 15, 2003
6593326	2,4-diamino pyrimidine compounds having anti-cell proliferative activity	Jul. 15, 2003
6586431	3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives	Jul. 1, 2003
6583136	Antifungal ethers	Jun. 24, 2003
6583155	Method for treating allergies using substituted pyrazoles	Jun. 24, 2003
6579874	Substituted azoles	Jun. 17, 2003
6579872	Bezamide derivatives for the treatment of diseases mediated by cytokines	Jun. 17, 2003
6573261	Method for treating or preventing psychosomatic and psychoimmunologic disorders	Jun. 3, 2003
6562817	Tricyclic compound	May. 13, 2003
6562813	Aralkyl and aralkylidene heterocyclic lactams and imides	May. 13, 2003
6559155	Pyrimidinone derivatives for the treatment of atherosclerosis	May. 6, 2003
6555537	Piperazine derivatives and their use as anti-inflammatory agents	Apr. 29, 2003
6548498	Substituted indan derivatives	Apr. 15, 2003
6548512	Nitrogen containing heteroaromatics as factor Xa inhibitors	Apr. 15, 2003